Gerresheimer AG (ETR:GXI) has been assigned a €65.00 ($76.47) price target by research analysts at Kepler Capital Markets in a report released on Friday. The brokerage presently has a “sell” rating on the stock. Kepler Capital Markets’ price target would indicate a potential downside of 2.45% from the company’s previous close.

A number of other equities analysts have also recently issued reports on the company. Commerzbank Ag set a €77.00 ($90.59) price objective on Gerresheimer AG and gave the stock a “buy” rating in a report on Monday, October 23rd. HSBC Holdings plc set a €65.00 ($76.47) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a report on Tuesday, October 17th. Deutsche Bank AG set a €64.00 ($75.29) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a report on Thursday, October 12th. Goldman Sachs Group, Inc. (The) set a €69.50 ($81.76) target price on Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, October 12th. Finally, Independent Research GmbH set a €68.00 ($80.00) target price on Gerresheimer AG and gave the company a “neutral” rating in a research note on Wednesday, October 11th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of €72.64 ($85.46).

ILLEGAL ACTIVITY WARNING: “Gerresheimer AG (GXI) PT Set at €65.00 by Kepler Capital Markets” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.watchlistnews.com/gerresheimer-ag-gxi-pt-set-at-65-00-by-kepler-capital-markets/1675210.html.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with Analyst Ratings Network's FREE daily email newsletter.